GlassScriptPhysician profile
Keith J Lerner
NPI 1124091202
$776.43
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $48.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $293.30 | 2019 | |
| Stryker Corporation | $149.50 | 2019 | |
| Novo Nordisk INC | $125.99 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.09 | 2019 | |
| Lilly USA, LLC | $51.31 | 2019-2020 | |
| Amarin Pharma, INC. | $39.46 | 2019 | |
| Merck Sharp & Dohme LLC | $28.05 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $19.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.